DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Keywords: other
| MO-E115-IePD-F6-4 | 4D-THRIVE MRI for Internal Target Volume Estimation in Abdominal and Lung Radiation Therapy J Deng, T Aguilera, R Hannan, A Godley*, University of Texas Southwestern Medical Ctr, Dallas, Texas |
| MO-H345-IePD-F7-1 | Automating Contouring and Treatment Planning for Pediatric 3D-Craniospinal Irradiation Therapy S Hernandez1,2*, J Parkes3, H Burger3, C Nguyen2, D Rhee2, A Paulino2, T Netherton1,2, R Mumme2, J Guma-de La Vega2, J Duryea2, C Cardenas4, R Howell1,2, D Fuentes1,2, J Pollard-Larkin1,2, L Court1,2, (1) UT MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX (2) The University of Texas MD Anderson Cancer Center, Houston, TX (3)Department of Radiation Oncology, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa (SA) (4) Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL |
| MO-I430-BReP-F2-3 | Target Volume Comparison Between Clinicians Comparing the Traditional 17segment Model and Direct Registration of Electroanatomic Maps in Stereotactic Arrhythmia Radioablation for Refractory Ventricular Tachycardia S Oh1, G Shaw2, A Thosani2, E Liu2, M Trombetta1, J Sohn1*, (1) Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, PA, (2) Division of Cardiac Electrophysiology, Cardiovascular Institute, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, PA |
| PO-GePV-M-5 | Geometric and Dosimetric Evaluation of An Atlas - Based Autosegmentation Software On Organs-At-Risk (OARs) for Tomotherapy Planning of Nasopharyngeal Carcinoma (NPC) Patients Y Wang1*, P Cheung1, J Lui2, F Lee2, L Wing Sum2, H Yiu2, J Cai1, (1) The Hong Kong Polytechnic University, Hong Kong, CN, (2) Queen Elizabeth Hospital, Hong Kong, HK |
| PO-GePV-M-159 | Impact of Parameter Selection and Setup Conditions On Image Quality of a Novel On-Board Helical KVCT R Tegtmeier*, W Ferris, J Bayouth, W Culberson, University of Wisconsin-Madison, Madison, WI |
| PO-GePV-M-291 | A Semi-Supervised Learning Method Using Soft-Label for Cell Nuclei Segmentation On Immunohistochemistry Images J Zhou1*, Z Yan2, J Polf3, H Zhang4, B Zhang5, M MacFarlane6, D Han7, M Zakhary8, A Gopal9, J Xu10, S Lee11, H Xu12, G Lasio13, S Chen14, (1) University of Maryland Shore Medical Center at Easton, Easton, MD, (2) Sense Brain, Princeton, NJ,(3) University of Maryland School of Medicine, Baltimore, MD, (4) University of Maryland School of Medicine, Baltimore, MD, (5) University of Maryland School of Medicine, Baltimore, MD, (6) University of Maryland School of Medicine, Baltimore, MD, (7) University of Maryland School of Medicine, Baltimore, MD, (8) University of Maryland School of Medicine, Baltimore, MD, (9) University of Maryland School of Medicine, Baltimore, MD, (10) University of Maryland School of Medicine, Baltimore, MD, (11) University of Maryland School of Medicine, Baltimore, MD, (12) University of Maryland School of Medicine, Baltimore, MD, (13) University of Maryland School of Medicine, Baltimore, MD, (14) University of Maryland School of Medicine, Baltimore, MD |
| PO-GePV-T-15 | A Machine Learning Prognostic Model for the Assessment of 177-Lu-DOTATATE Therapy Using Dose and Radiomics Features Analysis D Plachouris1, V Eleftheriadis2, T Nanos1, P Papadimitroulas2, L Vergnaud3, N Papathanasiou4, D Sarrut3, G C Kagadis1*, (1) Department of Medical Physics, School of Medicine, University of Patras, Rion, GR,(2) Bioemission Technology Solutions - BIOEMTECH, Athens, GR, (3) CREATIS, CNRS, Universite de Lyon, Lyon, FR, (4) Department of Nuclear Medicine, School of Medicine, University of Patras, Rion, GR |
| PO-GePV-T-66 | Stability of the FLASH Mobetron System A Palmiero*, A Glick, K Liu, N Chopra, D Neill, S Massia, E Schueler, S Beddar, UT MD Anderson Cancer Center, Houston, TX |
| PO-GePV-T-224 | On Mitigating the Effects of Imaging Dose During Patient Specific QA On a Moving ArcCheck Phantom Using the Accuray Radixact Real Time Tracking System R Teboh Forbang*, B Lewis, A Ndlovu, Hackensack University Medical Center, Hackensack, NJ |
| PO-GePV-T-251 | Exploration of One-Step Auto Planning: Tomotherapy MLC Sequence Prediction Yaoying Liu1,2, Xuying Shang1,2, Gaolong Zhang1, Xiaoyun Le1, Wei Zhao1, Chuanbin Xie2, Baolin Qu2, Shouping Xu3,* (1) Beihang University, School of Physics, Beijing, China. (2) The First Medical Center of PLA General Hospital, Department of Radiation Oncology, Beijing, China. (3) National Cancer Center/Cancer Hospital- Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Radiation Oncology, Beijing, China. |
| PO-GePV-T-261 | Hybrid Forward and Inverse Planning Approach For Lattice Radiation Therapy G Shukla*, A Mahadevan, Geisinger, Lewistown, PA |
| PO-GePV-T-293 | Dosimetric Analysis of Volumetric Modulated Arc Therapy for Extensive Skin Field Cancerization of the Scalp A Hafeez, T Nurushev, A Sutter, T Fox, B Koontz, W Curran, P Potrebko*, GenesisCare, Fort Myers, FL |
| PO-GePV-T-307 | Comparison of Manual, Isodose-Based, and Projection-Based PTV Contouring Methods for 3D Conformal Breast Cancer Treatment Planning P Jensen1,2*, Z Chen1,2, (1) Yale-New Haven Health, New Haven, CT, (2) Yale University School of Medicine, New Haven, CT |
| PO-GePV-T-339 | Development of Supplemental Pre-Treatment Daily Quality Assurance On the Radixact Real-Time Tumor Tracking System R Teboh Forbang*, B Lewis, A Ndlovu, Hackensack University Medical Center, Hackensack, NJ |
| PO-GePV-T-390 | Optimal Method of Radixact Treatment Planning for IROC Lung Phantom with Motion Table to Meet VALOR Protocol Constraints S Klash1*, E Mcclelland2, C Sobotka3, S Corbett4, (1) VAPHS, Pittsburgh, PA, (2) VAPHS, Pittsburgh, PA, (3) VAPHS, Pittsburgh, PA, (4) VAPHS, Pittsburgh, PA |
| PO-GePV-T-436 | Cell Morphometry for Advancing Nanoparticle-Mediated Radiotherapy Against Glioblastoma E Jank*, O Salas, A Benoit, Y Walter, A Hubbard, A Ekpenyong, Creighton University, Omaha, NE, USA. |
| SU-E-202-1 | Uncertainty Analysis of Absorbed Dose Calculation in Targeted Radiotherapy Using a Bayesian Approach M BENSIALI1*, E Davesne1,2, E Chojnacki1, D Broggio1, S Lamart1, N Anizan3, S Leboulleux3,4, D Franck1, (1) Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-roses,FR, (2) INSTN, Gif-sur-Yvette, FR, (3) Gustave Roussy and Paris Saclay University,Villejuif, FR ,(4) Geneva University Hospitals, Geneva, SW |
| SU-E-202-5 | Impact of Dosimetry Method On Organ and Tumor Absorbed Dose Estimates in Lutetium-177-DOTATATE Therapy of Neuroendocrine Tumors J Brosch-Lenz1*, A Rahmim1; 2; 3, C Uribe2; 3, (1) BC Cancer Research Institute, Vancouver, BC, CA, (2) University of British Columbia, Vancouver, BC, CA, (3) BC Cancer, Vancouver, BC |
| SU-I400-BReP-F2-4 | CBCT Forecasting - A Convolution-LSTM Based Machine Learning Framework for Predicting “ahead-Of-Time” Patient Anatomy, Dose to Be Delivered, and Dose Trend in Head and Neck Radiotherapy A Santhanam1*, B Stiehl1, M Lauria1, R Savjani1, S Gros2,D Low1, (1) University of California, Los Angeles, Los Angeles, CA, (2) Loyola University Chicago, Chicago IL |
| SU-K-206-7 | Targeted MR Contrast Nanoparticles for Programmed Death Ligand-1 Expression N Brown1,2*, G Bort3,4, P Rocchi3,4, L Carmes3,4, M Iyer1,2, T Doussineau3, F Lux3,4, J Schoenfeld2, M Dougan5, O Tillement3,4,6, R Berbeco2, (1) Northeastern University, Department of Physics Boston, MA, (2) Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Department of Radiation Oncology, Boston, MA,(3) NHTherAguix, Lyon, France, (4) Universite Claude Bernard, Lyon, France, (5) Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA,(6) Institut Lumie`re-Matie`re, UMR 5306, Universite Lyon1-CNRS, Universite de Lyon, Villeurbanne Cedex, France |
| SU-K-BRC-2 | Evaluation of Confidence Intervals in Daily Deformable Dose Accumulation in Parotid Glands to Guide Dose Adaptation During CT-Guided Radiation Therapy of Head and Neck Cancer J Garcia Alvarez*, K Kainz, H Zhong, C Schultz, X Li, Medical College of Wisconsin, Milwaukee, WI |
| TH-B-202-4 | Personalized Dosimetry for Thyroid Metastatic Cancers: An Ancillary Study of the MERAIODE Clinical Trial (NCT 03244956) Using OEDIPE Software S Lamart1*, N Anizan2, A Legrand1, M Bensiali1, D Broggio1, S Leboulleux2,3, (1) Institut de Radioprotection et de Surete Nucleaire, Fontenay-aux-roses, FR, (2) Gustave Roussy et Universite Paris Saclay, Villejuif, FR, (3) Geneva University Hospitals, Geneva, SW |
| TU-D1030-IePD-F4-1 | Radiosensitizationeffect and Therapeutic Benefits of Small Sized Gold Nanoparticles S Yasmin-Karim1Brigham and Women's Hospital, U Ibeh2, M Moreau3*, N Bih4, U Ngwa5, B Ziberi6, R Kumar7, G Makrigiorgos8, W Ngwa9, (1) Brigham and Women's Hospital, Boston, MA, (2) University of Massachusetts Boston, Boston, MA, (3) Johns Hopkins University, Columbia, MD, (4) Johns Hopkins University, Boston, MA, (5) Libertas Scholars Inc, ,,(6) University of Tetova, Tetova, Republic of North Macedonia, Boston, MA, (7) West Pharmaceutical Services, Inc., ,,(8) Dana Farber Cancer Institute, Boston, MA, (9) Johns Hopkins University, Boston, MA |
| TU-E-202-0 | ICRU Report On Dosimetry-Guided Radiopharmaceutical Therapy G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
| TU-E-202-1 | Introduction to the ICRU Report On Dosimetry-Guided Radiopharmaceutcal Therapy G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
| TU-E-202-2 | Nomenclature and Levels of Prescribing, Recording and Reporting G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
| TU-E-202-3 | RBE and Bioeffect Modeling G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
| TU-E-202-4 | Implementation Examples G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
| TU-E-202-5 | Q & A G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
| WE-E-BRA-1 | Advancing Radioimmunotherapy For Brain Tumors Using In Vitro Assays Y Walter*, O Salas, A Benoit, D Jordan, E Jank, A Hubbard, A Ekpenyong, Creighton University, Omaha, NE |
| WE-F-206-6 | Radiobiological Effects of Ultra-High FLASH Dose Rate Using X-Rays Generated by the Small Animal Radiation Research Platform D Goia*, K Shoniyozov, A Velalopoulou, I Verginadis, M Kim, E Diffenderfer, L Dong, C Koumenis, University of Pennsylvania, Philadelphia, PA |